2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.58+$0.007 (+1.23%)
Price as of Nov 12, 2026 8:15 AM EST- $65.6MMarket Cap
- -73.21%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.58+$0.007 (+1.23%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.57 | ||
Change | +$0.008 (+1.41%) | ||
Open | $0.57 | ||
High | $0.58 | ||
Low | $0.55 | ||
Previous Close | $0.56 | ||
Volume | 343,158 | ||
30-Day Average Volume | 526,761 | ||
1-Week Change | -0.84% | ||
1-Month Change | -28.91% | ||
1-Year Change | -73.21% | ||
3-Year Change | -71.31% | ||
5-Year Change | -98.01% | ||
Fundamentals | |||
Shares Outstanding | 115.4M | ||
Total Assets | $52.5M | ||
Market Cap | $65.6M | ||
Enterprise Value | $61.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.7M | ||
Free Cash Flow | -$7.9M | ||
EBIT | -$7.7M | ||
EBITDA | -$7.6M | ||
Net Working Capital | $39.3M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | N/A | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue